Executive Summary
The overnight filing slate is dominated by routine Q2 FY27 newspaper-publication and board-meeting intimations, but three disclosures carry real signal: Tata Chemicals' swing to a Q2 loss of ₹(50) crore (vs ₹154 crore profit in Q2 FY26) with DSCR weakening to 1.36x from 2.18x, Neogen Chemicals' 42% YoY revenue growth, 144% PAT jump and 6.5x oversubscribed ₹600 crore QIP, and BlueStone's 45% YoY Q3 FY27 QTD growth driven entirely by transaction volumes with flat realisations.
The common thread across the 18 filings is Q2 FY27 results season in full flow — at least 12 companies have either approved or published September-quarter results in the last 72 hours, setting up a dense catalyst window through mid-November. Sector divergence is stark: specialty chemicals shows a bifurcation between Neogen's battery-chemicals-led acceleration and Tata Chemicals' soda-ash/commodity margin collapse, while consumer discretionary (BlueStone) is signalling a strong festive season. Debt-market disclosures (Paisalo Digital's on-time NCD interest) confirm no immediate credit stress in that name, but Tata Chemicals' rising leverage (₹7,762 crore debt) is the single largest balance-sheet risk in the batch. With no insider trading data disclosed in any filing, conviction signals must be read from capital actions — Neogen's QIP and CRISIL upgrade being the strongest positive tell.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Corporate governance · Debt securities
Tracking the trend? Catch up on the prior India Pre-Market Regulatory Roundup digest from November 08, 2026.
Investment Signals (9)
- Neogen Chemicals ↓ (BULLISH)▲
Q2 FY27 consolidated revenue ₹296 crore (+42% YoY), EBITDA ₹45 crore (+51% YoY), PAT ₹8 crore (+144% YoY); battery chemicals revenue jumped to ₹37 crore from ₹5 crore YoY — a 7.4x scale-up that is the clearest new-economy growth vector in the batch
- Neogen Chemicals ↓ (BULLISH)▲
₹600 crore QIP completed with 6.5x oversubscription plus CRISIL outlook upgrade to A- stable — institutional demand and credit improvement in the same quarter is a rare double confirmation
- Neogen Chemicals ↓ (BULLISH)▲
Standalone EBITDA margin 18.6% with standalone EBITDA up 54% YoY to ₹54 crore; consolidated drag from Neogen Ionics fixed costs and Dahej rebuild is transient, implying margin expansion as those assets stabilise
- BlueStone Jewellery ↓ (BULLISH)▲
Q3 FY27 QTD (Oct 1–Nov 8) business up 45% YoY, entirely buyer-transaction driven with flat average realisations and improved entry-level price-point momentum — festive demand (Dhanteras/Diwali) is translating into volume, not just ticket-size inflation
-
H1 FY27 revenue up 11.0% YoY to ₹8,432 crore and Q2 revenue up 7.7% YoY to ₹4,177 crore — top-line resilience persists even as profitability collapses, suggesting the issue is cost/margin, not demand [MIXED/BULLISH on franchise]
- Tata Chemicals ↓ (MIXED)▲
Total comprehensive income improved to ₹198 crore in Q2 FY27 from ₹147 crore YoY — other comprehensive income is partially offsetting the P&L loss, a nuance the headline PAT number obscures
-
Quarterly interest on 9.75% NCD (₹34 crore issue size) paid on schedule November 08, 2026 — ₹83.55 lakh interest, no delay or default, next payment August 2028 cycle intact [NEUTRAL/BULLISH on credit]
- MphasiS ↓ (NEUTRAL)▲
1,52,891 equity shares allotted on ESOP/RSU exercise (1,37,391 under RSU Plan 2021, 15,500 under ESOP 2016) — routine but confirms ongoing employee retention machinery; dilution is negligible at this scale
- Q2 FY27 Results Season Density (MARKET STRUCTURE)▲
At least 12 of 18 filings relate to September-quarter results approved or published between Nov 6–8, 2026 — the market is entering peak information-flow week with results-driven re-rating risk across small and mid-caps
Risk Flags (9)
- Tata Chemicals↓ [HIGH RISK]▼
Q2 FY27 swung to a loss after tax of ₹(50) crore versus ₹60 crore profit in Q1 FY27 and ₹154 crore in Q2 FY26; H1 FY27 PAT collapsed 97.9% YoY to ₹10 crore from ₹470 crore — a near-total earnings wipeout
- Tata Chemicals↓ [HIGH RISK]▼
Debt service coverage ratio weakened to 1.36x from 2.18x YoY while outstanding debt rose to ₹7,762 crore from ₹7,495 crore — leverage rising into an earnings downturn is the classic deterioration pattern
- Tata Chemicals↓ [HIGH RISK]▼
Q2 FY27 loss before exceptional items and tax was ₹(26) crore versus ₹127 crore profit in Q1 FY27 and ₹246 crore in Q2 FY26; EPS swung to ₹(4.79) from ₹3.02 — operating profitability, not one-offs, is the problem
- Tata Chemicals↓ [MEDIUM RISK]▼
H1 FY27 EPS ₹(5.46) versus ₹12.91 — if Q3 does not inflect, full-year consensus cuts are likely; watch for guidance commentary at the earnings call
- BlueStone Jewellery↓ [MEDIUM RISK]▼
45% growth is provisional, unaudited, and disclosed without absolute revenue or profitability — volume-led growth with flat realisations may compress per-unit margins if discounting drove the transaction surge
- Neogen Chemicals↓ [MEDIUM RISK]▼
Consolidated net debt ₹1,095 crore against ₹465 crore liquid investments — net leverage remains elevated even after the QIP; Neogen Ionics fixed costs and Dahej rebuild overheads are actively suppressing consolidated EBITDA
- Disclosure Quality — Multiple Filings [MEDIUM RISK]▼
At least 8 filings (Caspian, Frontier Capital, Mawana Sugars, MKP Mobility, Autoline, Coffee Day, United Van Der Horst, AMPL Capital) contain illegible or unrelated newspaper content with no extractable financials — small-cap disclosure hygiene remains poor and raises information-asymmetry risk
- Arvaya Healthcare (formerly Bijoy Hans) [LOW-MEDIUM RISK]▼
Board meeting on 13/11/2026 with an undisclosed agenda and an unexplained name change from Bijoy Hans Ltd — microcap governance opacity; the agenda could include a capital action not yet visible
- Frontier Capital↓ [LOW RISK]▼
Filing's newspaper pages are dominated by an unrelated CBI FIR against Future Retail promoters over an alleged ₹2,236 crore loan fraud — no direct company impact but illustrates contagion risk in the small-cap financials news flow
Opportunities (8)
- Neogen Chemicals↓ (OPPORTUNITY)◆
Battery chemicals scaling from ₹5 crore to ₹37 crore YoY (7.4x) positions the company as a direct play on India's cell-manufacturing build-out; with ₹465 crore in FDs and a fresh ₹600 crore QIP, capacity expansion is fully funded — re-rating candidate if consolidated margins normalise as Ionics/Dahej costs annualise
- Neogen Chemicals↓ (OPPORTUNITY)◆
CRISIL A- stable outlook upgrade lowers future borrowing costs and widens the institutional investor base post-QIP — credit-driven re-rating often precedes equity re-rating by 1–2 quarters
- BlueStone Jewellery↓ (OPPORTUNITY)◆
45% QTD growth into the festive season with flat realisations implies market-share gains rather than gold-price inflation; if the trend holds through November, Q3 FY27 could be a breakout quarter — watch for the full Q3 print and any IPO/listing-related disclosures
- Tata Chemicals↓ (SPECULATIVE OPPORTUNITY)◆
If the Q2 loss is driven by transient soda-ash price weakness and Dahej-type one-offs, the stock could be a mean-reversion play — H1 revenue still grew 11% YoY and comprehensive income improved; contrarian entry only after Q3 confirms cost normalisation
-
Clean NCD servicing record (₹83.55 lakh interest paid on time, next cycle 2028) supports the credit story; any yield-seeking fixed-income allocation to the 9.75% paper is defensible on current evidence [OPPORTUNITY — DEBT]
- Q2 FY27 Results Catalyst Window (CATALYST)◆
Board meetings scheduled for Nov 12 (S.I. Capital), Nov 13 (Axel Polymers, Arvaya Healthcare) and Nov 14 (Reilly Homes NCD) will release fresh financials — pre-positioning ahead of small-cap results can capture post-announcement drift
- ◆
Results already approved (Nov 6–7) but financials not yet legible in filings — the detailed results filings on BSE/NSE websites are the next information event; sugar and auto-ancillary cycles are turning, so the actual numbers may surprise
- Coffee Day Enterprises↓ (CATALYST)◆
Q2 FY27 results published Nov 8 but figures not in the filing — the underlying results release is the real catalyst for this distressed-to-recovery name; any improvement in operating profitability would be material given the low base
Sector Themes (6)
- Specialty Chemicals Bifurcation◆
Neogen (+42% YoY revenue, +144% PAT) and Tata Chemicals (-1.8% QoQ revenue, swing to loss) sit at opposite ends of the same sector — battery/electronic chemicals are in an upcycle while commodity soda-ash is in a downcycle; stock selection within chemicals matters more than sector allocation right now
- Q2 FY27 Results Season Peak◆
12 of 18 filings are September-quarter results-related, with approval dates clustered Nov 6–8 and publication dates Nov 7–8 — the next 5 trading sessions will see a wave of small/mid-cap earnings that typically drives 5–15% single-stock moves; liquidity and disclosure quality will determine tradability
- Festive Demand Confirmation◆
BlueStone's 45% QTD growth with volume-led (not price-led) momentum is the first hard data point on India's 2026 festive consumption; if corroborated by other consumer prints this week, discretionary retail could see an earnings upgrade cycle
- Leverage Stress in Old-Economy Industrials◆
Tata Chemicals' DSCR fall from 2.18x to 1.36x alongside rising debt (₹7,762 crore) is a template for commodity-chemical and industrial names — watch for similar leverage deterioration in other Q2 prints this week
- Small-Cap Disclosure Quality Gap◆
8+ filings contained illegible or unrelated newspaper content, with several companies (Frontier Capital, United Van Der Horst) attaching pages carrying other companies' results — regulatory scrutiny of Regulation 47 compliance could increase, and investors should source numbers from exchange filings, not newspaper scans
- Capital Raising Window Open◆
Neogen's 6.5x oversubscribed ₹600 crore QIP plus CRISIL upgrade signals that quality mid-cap chemical names can raise growth capital on favourable terms — expect more QIP announcements in the sector over the next quarter
Watch List (8)
-
Q3 FY27 trajectory and any management guidance on soda-ash pricing, Dahej/one-off costs and debt reduction — the DSCR at 1.36x is the key metric to monitor; earnings call commentary on H2 recovery is the swing factor
-
Consolidated margin normalisation as Neogen Ionics fixed costs annualise and Dahej rebuild completes — watch Q3 consolidated EBITDA margin versus the 18.6% standalone benchmark; any further battery-chemicals order wins are upside
-
Full Q3 FY27 results (likely January 2027) to confirm whether 45% QTD growth converts into profitable growth; also watch for any IPO/listing-related filings given the company's profile
-
Board meeting November 13, 2026 to approve Q2/H1 FY27 results — trading window closed until 48 hours post-declaration; small-cap polymer name, expect volatility around the print
- S.I. Capital & Financial Services👁
Board meeting November 12, 2026 for Q2 FY27 results — earliest results catalyst in the batch; financial-services microcap, watch for asset-quality commentary
- Arvaya Healthcare (formerly Bijoy Hans)👁
Board meeting November 13, 2026 with undisclosed agenda and unexplained name change — verify the agenda via subsequent disclosure; potential corporate action catalyst
- Reilly Homes Realty👁
Board meeting November 14, 2026 for Q2/H1 FY27 results; NCD trading window closed since July 1, 2026 — debt investors should watch for any covenant or coverage disclosure
-
Detailed Q2 FY27 results already approved (Nov 6–7) but not legible in filings — pull the full results from exchange websites; sugar, auto-ancillary and coffee retail cycles are all at inflection points
Filing Analyses
(18)
08-11-2026
Axel Polymers Ltd. has notified BSE (Scrip Code: 513642) that its Board of Directors will meet on Friday, 13th November, 2026, to consider and approve Unaudited Financial Results for Q2 and H1 ended 30th September, 2026. The trading window under SEBI PIT Regulations will remain closed until 48 hours after the results are declared. The intimation is a routine Regulation 29 listing compliance disclosure with no financial figures or performance data disclosed.
- · Board meeting scheduled for Friday, 13th November, 2026
- · Results to cover Q2 and half year ended 30th September, 2026
- · Trading window closed until 48 hours after declaration of financial results
- · BSE Scrip Code: 513642; CIN: L25200GJ1992PLC017678
- · Registered office at Moxi, Sankarda-Savli Road, Tal. Savli, Dist. Vadodara - 391 780, Gujarat
- · Corporate office at Borivali (West), Mumbai - 400092
08-11-2026
S.I.Capital & Financial Services Limited has given prior intimation under Regulation 29 of SEBI LODR that its Board of Directors will meet on Thursday, November 12, 2026, to consider and approve the Unaudited Financial Results for the quarter ending September 30, 2026. The trading window will remain closed until 48 hours after the declaration of results for all designated persons and their immediate relatives under SEBI PIT Regulations. The filing contains no financial figures or performance data, so no period-over-period comparison is possible.
- · Board meeting scheduled for Thursday, November 12, 2026
- · Unaudited Financial Results to be considered for the quarter ending September 30, 2026
- · Trading window closed until 48 hours after declaration of financial results
- · BSE scrip code: 530907
- · CIN: L67190TZ1994PLC040490
- · Registered office: No. 28, Second Floor, New Scheme Road, Pollachi, Coimbatore, Tamil Nadu 642001
- · Company website: www.sicapital.co.in
08-11-2026
Max Earth Resources Ltd (formerly Max Alert Systems Ltd) disclosed via newspaper advertisement that its unaudited financial results for the quarter ended September 30, 2026 were approved by the Board on November 06, 2026 and published on November 08, 2026 in The Standard Post and Pratahkal, in compliance with SEBI Regulations 30 and 47. The filing itself contains no financial figures or performance metrics — the attached newspaper pages are general news content unrelated to the company's results, so no revenue, profit, or period-over-period comparison can be assessed. Sentiment is neutral given the purely procedural nature of the disclosure.
- · Scrip Code: 534563
- · CIN: L74999MH2004PLC144034
- · Board meeting approving results held November 06, 2026
- · Results published in newspapers on November 08, 2026
- · Company website: http://www.maxearth.in
- · Registered office: 103 Wellington Business Park 1, Andheri-Kurla Road, Marol, Mumbai - 400059
- · No actual financial figures (revenue, profit, EPS) were included in the filing content
08-11-2026
Caspian Corporate Services Limited submitted newspaper clippings of its unaudited standalone and consolidated financial results for the quarter and half year ended 30 September 2026, published in Financial Express (English) and Mana Telangana (Telugu) on 08 November 2026, pursuant to Regulation 47 of SEBI LODR Regulations, 2015. The filing is a routine compliance disclosure confirming publication of results; the underlying financial figures are not legible in the submitted clipping text, so no period-over-period performance can be quantified from this filing.
- · BSE Scrip Code: 534732
- · Results cover the quarter and half year ended 30 September 2026
- · Clippings published in Financial Express (English) and Mana Telangana (Telugu) dated 08 November 2026
- · Company CIN begins with L74 (Telangana-registered entity); registered office at Surya Towers, Hyderabad, Telangana
- · Filing digitally signed by S T Mulla on 2026.11.08 at 20:40:14 +05:30
- · Company formerly known as Private Capital Advisors Limited
08-11-2026
Frontier Capital Limited published newspaper advertisements on November 08, 2026, disclosing an extract of its Unaudited Standalone Financial Results for the quarter and half year ended September 30, 2026, as approved by the Board at its meeting held on November 07, 2026. The disclosure was made under Regulation 30 and Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, in Active Times (English) and Mumbai Lakshadeep (Marathi). The filing itself contains no financial figures from the results; the attached newspaper pages are dominated by unrelated public notices and market commentary, including a CBI FIR against Future Retail and its promoter-directors Kishore Laxminarayan Biyani and Rakesh Gopikishan Biyani over an alleged ₹2,236 crore loan fraud.
- · Board meeting to approve the unaudited standalone financial results was held on November 07, 2026
- · Newspaper advertisements published on November 08, 2026 in Active Times (English, Mumbai) and Mumbai Lakshadeep (Marathi, Mumbai)
- · Filing made under Regulation 30 and Regulation 47 of SEBI Listing Regulations, 2015
- · Scrip Code: 508980; Script Symbol: FRONTCAP; CIN: L65990MH1984PLC033128
- · Registered office: Office No.-1206, Lodha Supremus, Senapati Bapat Marg, Lower Parel, Mumbai – 400013
- · CBI FIR (RC0772026E0011) registered on November 4, 2026 against Future Retail and its promoter-directors, following an October 9, 2026 complaint by SBI; IPC Section 120-B read with 420 and Prevention of Corruption Act Sections 13(2), 13(1)(d) and 13(1)(a) invoked (third-party news, not a Frontier Capital matter)
- · No actual financial result figures (revenue, profit, EPS) are legible or disclosed in the filing text
08-11-2026
Reilly Homes Realty Private Limited has given prior intimation under Regulation 50(1) of the SEBI Listing Regulations that its Board of Directors will meet on Saturday, November 14, 2026 to consider and approve the Unaudited Financial Results for the quarter and half year ended September 30, 2026. The trading window for dealing in the company's listed Non-convertible Debentures has been closed with effect from July 1, 2026 and will reopen 48 hours after the outcome of the meeting is announced. No financial figures or performance metrics were disclosed in this filing.
- · Board meeting scheduled for Saturday, November 14, 2026
- · Financial results to be considered are for the quarter and half year ended September 30, 2026
- · Trading window closed with effect from July 1, 2026 and will open 48 hours after announcement of meeting outcome
- · Company CIN: U68200KA2024PTC189347; registered office at Embassy Manyata Business Park, Bengaluru-560045
- · Filing made under Regulation 50(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- · Copy marked to Catalyst Trusteeship Limited, Pune – 411 038
08-11-2026
Mawana Sugars Limited disclosed via a Regulation 47 newspaper publication that its unaudited financial results for the quarter ended 30 September 2026 were published in Jansatta (Hindi, Delhi edition) and Financial Express (English, all editions) on 8 November 2026. The filing itself is a routine compliance intimation and contains no financial figures; the attached newspaper pages are largely illegible and appear to include unrelated content (e.g., a Rabindra Bharati University recruitment cancellation notice and Fratelli Vineyards/Tinna Trade results), so no reliable Mawana-specific numbers can be extracted.
- · Results are for the quarter ended 30 September 2026 (Q2 FY27)
- · Publication date: 8 November 2026; filing reference MSL/BSE/NSE/ 08 November 2026
- · BSE scrip code 523371; NSE symbol MAWANASUG
- · Company CIN: L74100DL1961PLC003413
- · Registered office: 5th Floor, Kirti Mahal, 19 Rajendra Place, New Delhi-110025; Corporate office: Plot No. 03, Institutional Area, Sector-32, Gurugram-122001
- · Filing signed digitally by Ashok Kumar Shukla on 2026.11.08 at 19:10:36 +05:30
- · Attached newspaper pages are illegible/mixed with unrelated third-party notices; no verifiable Mawana financial figures could be extracted
08-11-2026
MKP Mobility Limited (Scrip Code 521244, CIN L45300PN1990PLC242336) published newspaper notices on November 08, 2026 in Navarashtra (Pune) and Financial Express (Pune) disclosing its Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026, in compliance with Regulation 47 of SEBI LODR Regulations, 2015. The results were reviewed and recommended by the Audit Committee and approved by the Board at meetings held on November 06, 2026, and are posted on the company website with a QR code. The filing itself contains no numerical financial figures — only the publication intimation — so no revenue, profit, or period-over-period performance data can be assessed from this document.
- · Results cover the quarter and half year ended September 30, 2026 (Standalone & Consolidated)
- · Board and Audit Committee meetings approving results held on November 06, 2026
- · Newspaper publication dated Sunday, November 08, 2026
- · Scrip Code: 521244; CIN: L45300PN1990PLC242336
- · Registered office: GAT NO.624, Behind Vijay Hotel, Wadki Nala, Vadki, Pune, Haveli, Maharashtra, 412308
- · Results available on company website with QR code access
- · No financial figures (revenue, profit, EPS) are disclosed in this filing text
08-11-2026
Tata Chemicals reported Q2 FY27 revenue from continuing operations of ₹4,177 crore, down 1.8% QoQ from ₹4,255 crore and up 7.7% YoY from ₹3,877 crore, while H1 FY27 revenue rose 11.0% YoY to ₹8,432 crore. Profitability deteriorated sharply: Q2 FY27 swung to a loss after tax of ₹(50) crore versus a profit of ₹60 crore in Q1 FY27 and ₹154 crore in Q2 FY26, with H1 FY27 PAT collapsing 97.9% YoY to ₹10 crore from ₹470 crore. Total comprehensive income improved to ₹198 crore in Q2 FY27 from ₹147 crore a year ago, but outstanding debt rose to ₹7,762 crore from ₹7,495 crore YoY and the debt service coverage ratio weakened to 1.36x from 2.18x.
- · Q2 FY27 loss before exceptional items, share of JV/associate profit and tax was ₹(26) crore, versus ₹127 crore in Q1 FY27 and ₹246 crore in Q2 FY26
- · Q2 FY27 loss before tax was ₹(6) crore versus ₹110 crore in Q1 FY27 and ₹236 crore in Q2 FY26; H1 FY27 PBT was ₹104 crore versus ₹596 crore
- · Q2 FY27 basic and diluted EPS was ₹(4.79) versus ₹3.02 in Q2 FY26; H1 FY27 EPS was ₹(5.46) versus ₹12.91
- · Debt service coverage ratio fell to 1.36x in Q2 FY27 from 2.18x in Q2 FY26 and 4.78x in Q1 FY27; H1 FY27 was 2.36x versus 2.86x
- · Debt equity ratio was 0.34x as at September 30, 2026 versus 0.32x a year earlier and 0.35x in Q1 FY27
- · Interest service coverage ratio was 2.52x in Q2 FY27 versus 3.75x in Q1 FY27
- · Board approved the results at its meeting on Saturday, November 7, 2026; results were published in Financial Express, The Free Press Journal and Navshakti on November 8, 2026
- · Results comprise unaudited consolidated and audited standalone financials for Q2/H1 ended September 30, 2026; scrip code 500770, NSE symbol TATACHEM
08-11-2026
Paisalo Digital Limited certified under Regulation 57 of SEBI LODR that it duly paid quarterly interest on its 9.75% NCD (ISIN INE420C07148) on the scheduled due date of November 08, 2026, with no delay or default reported. The interest paid was Rs. 83,55,616.07 (inclusive of TDS) on an issue size of Rs. 34 Crore, with the next interest payment cycle following the prior payment on August 08, 2026 and redemption scheduled for August 08, 2028.
- · Interest payment record date was October 24, 2026
- · Previous interest payment date was August 08, 2026
- · Redemption date for the NCD is August 08, 2028
- · Interest payment frequency is quarterly with no change in frequency
- · No reason for non-payment or delay reported (N.A.)
08-11-2026
Autoline Industries Limited (BSE: 532797, NSE: AUTOIND) published newspaper advertisements in Financial Express (English) and Loksatta (Marathi) on November 07, 2026, disclosing its Financial Results for the Quarter & Half Year ended September 30, 2026, in compliance with Regulation 47 of SEBI LODR Regulations, 2015. The filing itself is a procedural newspaper-publication intimation signed by Company Secretary & Compliance Officer Pranvesh Tripathi from Pune; the underlying financial figures in the advertisement text are not legible in the provided filing, so no revenue, profit, or period-over-period comparisons can be reliably extracted.
- · Results cover the Quarter & Half Year ended September 30, 2026
- · Advertisements published Saturday, November 07, 2026; filing dated November 08, 2026
- · Scrip Code 532797 (BSE); Symbol AUTOIND (NSE)
- · Filing signed at Pune on 2026.11.08 at 17:04:17 +05'30'
- · Actual financial figures from the newspaper advertisement are not legible in the filing text provided
08-11-2026
Coffee Day Enterprises Limited published newspaper advertisements on November 8, 2026, in Business Line and Prajavani disclosing its unaudited financial results for the quarter ended September 30, 2026, in compliance with Regulation 47 of SEBI LODR Regulations. The filing itself contains no financial figures — the attached advertisement pages reproduced are general market commentary on an AI-driven Nasdaq-100 selloff and a base metals outlook, not the company's results. No revenue, profit, or period-over-period performance data for Coffee Day was disclosed in the filing text.
- · Newspapers used for publication: Business Line and Prajavani
- · Scrip Code: 539436; NSE Symbol: COFFEEDAY
- · CIN: L55101KA2008PLC046866
- · Company Secretary Membership No.: F5223
- · Filing signed and dated November 8, 2026 at 16:48:39 +05:30
- · Registered office: No.165, R.V. Road, Near Minerva Circle, Bangalore-560004
08-11-2026
Neogen Chemicals reported Q2 FY27 consolidated revenue of INR 296 crore, up 42% YoY, with EBITDA up 51% to INR 45 crore and PAT up 144% to INR 8 crore. Battery chemicals revenue jumped to INR 37 crore from INR 5 crore YoY, and the company completed a INR 600 crore QIP (6.5x oversubscribed) and received a credit rating outlook upgrade to CRISIL A- stable. However, consolidated EBITDA was impacted by initial fixed costs at Neogen Ionics and Dahej rebuild overheads, while standalone EBITDA grew 54% to INR 54 crore with an 18.6% margin.
- · Standalone EBITDA margin was 18.6% in Q2 FY27.
- · Consolidated net debt stood at INR 1,095 crore as of September 30, 2026, while standalone net debt was INR 378 crore.
- · Liquid investments in fixed deposits were INR 465 crore as of September 30, 2026.
- · Insurance recoveries to date total INR 164 crore, including INR 155 crore on-account payment and INR 9 crore from salvage realisation.
- · An additional insurance claim of INR 152 crore was accepted on October 29, 2026, taking total claims received and receivable to INR 316 crore.
- · The QIP was oversubscribed 6.5x.
- · Organolithium capacity is being doubled from 300 metric tonnes per annum to 600 metric tonnes per annum with a capex of up to INR 45 crore.
- · Neogen Ionics executed a business transfer agreement for the lithium-ion electrolyte salt undertaking for a cash consideration of INR 245 crore, including INR 77 crore already infused by Morita.
- · Battery chemicals revenue was INR 17 crore in Q1 FY27 and INR 37 crore in Q2 FY27.
- · The company expects to complete the Organolithium expansion by end of H1 FY28, contributing INR 50 crore to INR 75 crore additional revenue next year and INR 150 crore to INR 200 crore in the year after.
- · FY28 net debt is guided at INR 1,300 crore to INR 1,500 crore.
- · Battery chemicals revenue guidance for FY27 is INR 250 crore to INR 300 crore, and for FY28 it is INR 1,000 crore plus.
- · Consolidated revenue guidance for FY27 is INR 1,350 crore to INR 1,400 crore.
- · Base business revenue guidance for FY27 is INR 1,100 crore plus, and for FY28 it is INR 1,200 crore to INR 1,300 crore.
- · The company targets 20%+ return on capital on an investment of INR 1,800 crore to INR 2,000 crore, generating INR 2,500 crore to INR 3,000 crore revenue and INR 500 crore plus EBITDA at full utilisation by FY29.
- · Inventory days are targeted at around 180 days by end of FY27, 140-160 days in FY28, and 110-140 days in FY29-30.
08-11-2026
Arvaya Healthcare Ltd (formerly Bijoy Hans Ltd, BSE: 524723) has notified BSE under SEBI LODR Regulation 29(1) that its Board of Directors will meet on 13/11/2026 to consider and approve an undisclosed agenda item. The filing is a routine board meeting intimation with no financial, leadership, or operational details disclosed; no dividend, capital action, or results-related agenda is explicitly stated.
- · Company name in filing: Arvaya Healthcare Ltd; source summary references Bijoy Hans Ltd with BSE scrip code 524723 — name change or dual reference not explained in filing
- · Board meeting date: 13/11/2026
- · Filing date: 08/11/2026 (5 days prior to meeting)
- · Agenda described only as 'Pursuant to the provisions ....' — truncated; specific resolution item NOT_DISCLOSED
- · No financial results, dividend, buyback, bonus, rights issue, or M&A agenda explicitly stated
08-11-2026
United Van Der Horst Ltd filed a newspaper advertisement extract of its unaudited standalone and consolidated financial results for the quarter and half year ended 30 September 2026, published in Active Times and Mumbai Lakshdeep on 7 November 2026 under Regulation 47 of SEBI LODR. The filing itself contains no company-specific financial figures beyond the advertisement notice; the newspaper page also carried results of unrelated companies (Organic Coatings, Odyssey Corporation, Apollo Ingredients, Silverline Technologies, Filmcity Media, I Street Network, Jattashankar Industries, Vision Corporation). The disclosure is a routine compliance intimation with no new material financial data on the company's performance.
- · Filing dated 08-11-2026 addressed to BSE Limited, Scrip Code 522091
- · Results cover the quarter and half year ended 30 September 2026
- · Advertisements published in Active Times and Mumbai Lakshdeep Regional Daily on Saturday 7 November 2026
- · United Van Der Horst Limited CIN: L99999MH1987PLC044151, Registered Office E-29/30, MIDC Industrial Area, Taloja, Navi Mumbai - 410208
- · Disclosure made under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
08-11-2026
MphasiS Limited disclosed that its ESOP Compensation Committee approved the allotment of 1,52,891 equity shares on 8 November 2026 following the exercise of employee stock options and restricted stock units. The bulk of the allotment (1,37,391 shares) came from the RSU Plan 2021, while 15,500 shares were allotted under ESOP 2016. The filing is a routine SEBI Regulation 30 intimation with no financial performance or revenue data disclosed.
- · ESOP Compensation Committee resolution passed on 8 November 2026 approving the allotment
- · Scrip Code 526299 on BSE and Scrip Symbol MPHASIS on NSE
- · Cashless Scheme approved by shareholders under Section 67 of the Companies Act, 2013 at the 33rd Annual General Meeting held on 25 July 2024
- · RSU Plan 2021 approved by shareholders under Section 67 of the Companies Act, 2013 at the 30th Annual General Meeting held on 29 September 2021
- · Trusts will deduct shares to cover exercise price funded and applicable taxes, with sale proceeds used to repay loans from the Company
09-11-2026
AMPL Capital Limited (formerly Credent Global Finance Limited) disclosed newspaper advertisements of its unaudited standalone and consolidated financial results for the quarter and half year ended 30.09.2026, published in Financial Express (English) and Pratahkal (Marathi). The filing is a routine SEBI Regulation 30/47(3) compliance intimation; the actual financial figures in the attached advertisements are not legible in the provided text, so no performance metrics can be verified.
- · Results cover the quarter and half year ended 30.09.2026
- · Advertisement published on 07th September 2026 (as stated in the letter)
- · Company symbol: AMPL; Scrip Code: 539598
- · CIN: L65910MH1991PLC404531
- · Registered office: Unit No. 1216, 12th Floor, C-Wing, One BKC, Bandra Kurla Complex, Mumbai-400051
- · Filing signed by Aditya Vikram Kanoria, Managing Director, dated 09.11.2026
09-11-2026
BlueStone Jewellery and Lifestyle Limited reported a 45% YoY growth in business for Q3 FY27 quarter-to-date (October 1 to November 8, 2026), driven entirely by an increase in buyer transactions while average realisations remained flat compared to the same period last year. The growth was supported by festive demand during Dhanteras and Diwali, with improved momentum in entry-level price points. However, the company did not disclose absolute revenue figures or profitability metrics, and the update is provisional and unaudited.
- · Growth was buyer transaction driven, with average realisations flat YoY.
- · The update covers the period October 1, 2026 to November 8, 2026 (Q3 FY27 QTD).
- · The festive period included Dhanteras and Diwali.
- · Product range across entry-level price points saw improved momentum.
- · All figures are provisional, unaudited, and subject to audit review.
- · No absolute revenue or profitability figures were disclosed.
Get daily alerts with 9 investment signals, 9 risk alerts, 8 opportunities and full AI analysis of all 18 filings
₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: India Pre-Market Regulatory Roundup
🇮🇳 More from India
View all →November 09, 2026
India Upcoming Corporate Actions BSE NSE — November 09, 2026
India Upcoming Corporate Actions BSE NSE
November 09, 2026
India Quarterly Results BSE NSE Announcements — November 09, 2026
India Quarterly Results BSE NSE Announcements
November 09, 2026
India Corporate Governance MCA ROC Filings — November 09, 2026
India Corporate Governance MCA ROC Filings
November 09, 2026
India Stock Market Daily Regulatory Digest — November 09, 2026
India Stock Market Daily Regulatory Digest